THROMBOLYTIC THERAPY.
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000925:Anticoagulants; D035843:Biomedical Research; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005340:Fibrinogen; D005341:Fibrinolysin; D006470:Hemorrhage; D006801:Humans; D010958:Plasminogen; D011655:Pulmonary Embolism; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D015912:Thrombolytic Therapy; D013924:Thrombophlebitis; D013927:Thrombosis; D014116:Toxicology
D000614:Aminocaproates; D000925:Anticoagulants; D005340:Fibrinogen; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; ANTICOAGULANTS; CLINICAL RESEARCH; DRUG THERAPY; FIBRINOGEN; FIBRINOLYSIN; HEMORRHAGE; PLASMINOGEN; PULMONARY EMBOLISM; REVIEW; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS; THROMBOSIS; TOXICOLOGIC REPORT